ANALYTICAL TECHNIQUES
• Genetic amplification by PCR: qualitative and quantitative
• Real-Time PCR
• MSP (specific PCR amplification of methylated DNA)
• RFLP (Restriction Fragments Length Polymorphism)
• SSCP (Single Stranded Conformation Polymorphism)
• SNPs (Single Nucleotide Polymorphisms)
• DNA Chips
• DNA sequencing
• Gene fragment cloning
• Flow Cytometry
• Cell culture:
- Nucleic acid sequencing
- Microsatellite instability studies
- Nucleic acid Hybridisation: |
| |
-
Northern blot (RNA)
-
Southern blot (DNA) |
FIELDS OF ACTION
NEUROGENETIC, MONOGENIC AND HEREDITARY METABOLIC DISEASES
• Primary degenerative dementia
• Hereditary Polyneuropathies
• Movement disorders
• MitochonDrial Encephalopathies
• Hereditary Mental Retardation synDromes
• Hereditary Myopathies
• Hereditary Hemochromatosis
• Cystic Fibrosis or mucoviscidosis
• Tay-Sachs Disease
• Phenylketonuria
• Homocysteine
HUMAN ANEUPLOIDIES
• Down’s SynDrome detection by QF-PCR
• Chromosome 18 Trisomy by QF-PCR
• Chromosome 13 Trisomy by QF-PCR
• Human Aneuploidy detection in sex chromosomes by QF-PCR
ASSESSMENT OF GENETIC RISK TO COMMON DISEASE
• Vascular disease (cerebrovascular disease, cardiovascular disease, peripheral vascular disease)
• Osteoporosis
• Arterial Hypertension
• Coronary heart disease
• Chronic Obstruction Pulmonary Disease
• Mellitum Diabetes
• Celiac Disease
HAEMATOLOGICAL DISEASES
• Thrombophilias
• Alfa and beta Thalassemias hemoglobinopaties
ONCOLOGICAL DISEASES
• Solid Tumours and Haematological Tumours
• Study of Oncogenes, Tumour Supressor Genes and DNA Repair Genes, as prognostic, diagnostic and follow-up factors:
|
| |
- Quantification of gene expression
- Mutation pattern studies
- Determination of gene amplification
- Study of inherited disorders
- Minimal Residual Disease
- Gene rearrangement identification |
PHARMACOGENETICS STUDIES
• Cytochromo P450 complex:
|
| |
- CYP2D6
- CYP2C19
- CYP3A5 |
| • Acetylation: |
| |
- NAT2 |
| • Antidementia Drugs: |
| |
- APOE |
| • Antihypertensive Drugs: |
| |
- ACE |
| • Estrogen replacement therapy: |
| |
- COMT |
| • Hyperhomocysteinemia: |
| |
- MTFHR
- CBS
- MS |
| • Beta-ADrenergic receptor Snps |
| |
- Arg16Gly: Respuesta a tratamiento
antiasmático
- Gln27Glu: Obesity |
| • Specific inhibitors of Tyrosine Kinases: |
| |
- bcr/abl: Respuesta al Imatinib |
FORENSIC GENETICS
• Paternity Testing
|